Clinical Trial Update: Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy of ulinastatin to reduce radiation-induced oral mucositis in patients with nasopharyngeal carcinoma, and the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Oral Mucositis

Drugs mentioned

• Ulinastatin (ulinastatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Oral Mucositis (Ulcerative) Due to Radiation | Phase 3 | Status: COMPLETED